Header Logo

Connection

James Mulshine to Peptides

This is a "connection" page, showing publications James Mulshine has written about Peptides.
Connection Strength

0.879
  1. Effect of gastrin-releasing peptide on the pancreatic tumor cell line (Capan). Mol Carcinog. 1993; 8(4):214-20.
    View in: PubMed
    Score: 0.099
  2. The correct dose: pharmacologically guided end point for anti-growth factor therapy. Cancer Res. 1992 May 01; 52(9 Suppl):2743s-2746s.
    View in: PubMed
    Score: 0.095
  3. Preclinical evaluation of an anti-autocrine growth factor monoclonal antibody for treatment of patients with small-cell lung cancer. J Natl Cancer Inst. 1991 Oct 16; 83(20):1470-6.
    View in: PubMed
    Score: 0.091
  4. Peptide structure. Beyond transcriptional events. Nature. 1989 Feb 02; 337(6206):406.
    View in: PubMed
    Score: 0.076
  5. Solid-phase peptide quantitation assay using labeled monoclonal antibody and glutaraldehyde fixation. Anal Biochem. 1988 Oct; 174(1):224-34.
    View in: PubMed
    Score: 0.074
  6. Clinical use of a monoclonal antibody to bombesin-like peptide in patients with lung cancer. Ann N Y Acad Sci. 1988; 547:360-72.
    View in: PubMed
    Score: 0.070
  7. Consideration of the chemistry of solid-phase matrix interaction leads to improved quantitation of neuropeptides. Ann N Y Acad Sci. 1988; 547:41-53.
    View in: PubMed
    Score: 0.070
  8. Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer. Chest. 1997 Jul; 112(1):256-61.
    View in: PubMed
    Score: 0.034
  9. Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J Clin Invest. 1996 Feb 01; 97(3):806-13.
    View in: PubMed
    Score: 0.031
  10. Scientific basis for cancer prevention. Intermediate cancer markers. Cancer. 1993 Aug 01; 72(3 Suppl):978-83.
    View in: PubMed
    Score: 0.026
  11. Initiators and promoters of lung cancer. Chest. 1993 Jan; 103(1 Suppl):4S-11S.
    View in: PubMed
    Score: 0.025
  12. Prospective trial evaluating immunocytochemical-based sputum techniques for early lung cancer detection: assays for promotion factors in the bronchial lavage. J Cell Biochem Suppl. 1993; 17F:175-83.
    View in: PubMed
    Score: 0.025
  13. Control of tumor cell biology through regulation of peptide hormone processing. J Natl Cancer Inst Monogr. 1992; (13):169-75.
    View in: PubMed
    Score: 0.023
  14. Growth factors and other targets for rational application as intervention agents. Adv Exp Med Biol. 1992; 320:81-8.
    View in: PubMed
    Score: 0.023
  15. Alpha-amidation of peptide hormones in lung cancer. Cancer Cells. 1991 Dec; 3(12):504-10.
    View in: PubMed
    Score: 0.023
  16. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo. Cancer Res. 1991 Apr 01; 51(7):1798-802.
    View in: PubMed
    Score: 0.022
  17. Autocrine growth factors as therapeutic targets in lung cancer. Chest. 1989 Jul; 96(1 Suppl):31S-34S.
    View in: PubMed
    Score: 0.020
  18. In vivo diagnosis and therapy of human tumors with monoclonal antibodies: selection of antibodies and preliminary clinical studies in small cell carcinoma of the lung. Int J Rad Appl Instrum B. 1989; 16(2):159-62.
    View in: PubMed
    Score: 0.019
  19. Gastrin-releasing peptide and other autocrine growth factors in lung cancer: pathogenetic and treatment implications. Important Adv Oncol. 1988; 55-64.
    View in: PubMed
    Score: 0.018
  20. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature. 1985 Aug 29-Sep 4; 316(6031):823-6.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.